Stock Market News: Economy, Policy & Company Updates
EquityTimer summarises official corporate filings and market announcements into short, factual updates you can read in seconds. Every card is drawn directly from primary sources — BSE corporate announcements in India and SEC filings in the US — covering results, dividends, mergers, management changes and regulatory actions. Summaries are checked against the original document before publication, and each card links back to the filing so you can read it in full.
- All 339
- Results 228
- Management 60
- Agreement 17
- Regulatory 13
- Ownership 13
- Accounting 4
- M&A 3
- Restructuring 1
FedEx appoints Jamere Jackson as chief financial officer, effective Nov. 30, 2026
FedEx Corp. announced that Jamere Jackson was appointed chief financial officer, effective November 30, 2026, succeeding interim CFO Claude Russ. Jackson previously served as CFO of AutoZone, Hertz Global Holdings and Nielsen Holdings and currently sits on Eli Lilly’s board. FedEx reported annual revenue of $86 billion. CEO Raj Subramaniam said Jackson’s disciplined financial strategy would support profitable growth.
Citigroup elects James Flanagan as independent director to its board
Citigroup announced that its board elected James (Jim) Flanagan as a new independent director, effective immediately. Flanagan spent nearly 40 years at PricewaterhouseCoopers, including roles as audit partner, practice leader and COO/Vice Chairman from 2014‑2021, overseeing U.S. operations, risk and regulatory matters. He also serves on the boards of Integer Holdings and Cyabra, Inc., where he chairs the Audit Committee.
Bank of America expands board to 14 directors, appoints James Fitterling and William Thomas
On October 21, 2026, Bank of America Corporation announced that its Board of Directors increased its size from 12 to 14 members. The company appointed James Fitterling and William Thomas to the Board, with both individuals beginning their service immediately. This change was disclosed in a Form 8‑K filing with the SEC.
Vertex Pharmaceuticals adds Daniel Brennan to board, expanding it to 11 members
Vertex Pharmaceuticals appointed Daniel Brennan to its board of directors on October 20, 2026, expanding the board to eleven members. Mr. Brennan, EVP and CFO of Boston Scientific, joined the Audit and Finance Committee, received a $400,000 stock unit award vesting in October 2027, and has served on the boards of Waters Corporation since 2022 and Madrigal Pharmaceuticals since 2025, holding an MBA CPA designation.
TJX Companies reports Kenneth Canestrari’s retirement effective April 30, 2027
On October 15, 2026, TJX Companies announced that Kenneth Canestrari will retire on April 30, 2027. His employment agreement was extended to that date, after which he will no longer serve as an executive officer. He will not participate in the Management Incentive Plan, LRPIP for fiscal year 2028 onward, or receive new stock awards, while retaining benefits and remaining subject to confidentiality obligations.
Medtronic appoints Michael Marinaro as President with $1 million salary and $3.25 million long‑term incentives
Medtronic plc appointed Michael Marinaro, EVP and President of Medical Surgical Portfolio, Americas, as President effective Oct. 14, 2026. His base salary was raised to $1,000,000 for fiscal 2027 and he will receive long‑term incentive awards worth $3.25 million, comprising a $1.625 million performance share unit, a $975,000 stock option grant and a $650,000 restricted stock unit, to be granted on Nov. 2, 2026.
Costco approves FY2027 executive bonus plan with up to $1.2 million for CEO
Costco Wholesale Corp disclosed that its Compensation Committee approved fiscal 2027 bonus criteria for executives. Non‑CEO officers are eligible for a base bonus of $400,000, split equally between sales and pre‑tax income targets, with potential payouts up to 120% of each target and up to $80,000 for environmental and social goals. The CEO’s base bonus is $1.2 million, plus up to $200,000 for ESG metrics.
AbbVie expands board to 13 directors, appoints Dr. John M. Carethers as Class II director
AbbVie Inc. announced on October 14, 2026 that it increased its Board of Directors from twelve to thirteen members and appointed Dr. John M. Carethers as a Class II director. Dr. Carethers, Vice Chancellor for Health Sciences at UC San Diego and former Avantor director, will serve on the Public Policy and Sustainability Committee and will receive compensation for independent directors as disclosed in the company’s Form 10‑Q for the quarter ended March 31, 2025.
Halliburton appoints David C. Hernandez to its board of directors
On October 15, 2026, Halliburton announced the appointment of David C. Hernandez as a director, filling a vacancy and keeping the board at 12 members. Hernandez, president and director of Hunt Consolidated, will serve until the 2027 annual meeting and was placed on the Audit Committee and the Health, Safety and Environment Committee. The board determined he is independent under NYSE standards.
Caterpillar appoints Derrick York as group president of Resource Industries after Denise Johnson retirement
On Oct. 15, 2026 Caterpillar Inc. disclosed that Denise Johnson, group president of Resource Industries, will retire effective Feb. 1, 2027 and will serve in an advisory role. Derrick York, president of Solar Turbines and vice president, was appointed group president of Resource Industries effective Nov. 1, 2026. York has led the global industrial gas turbine business since 2023 and has 16 years with Caterpillar.
FedEx appoints Jamere Jackson as chief financial officer, effective Nov. 30, 2026
FedEx Corp. announced that Jamere Jackson was appointed chief financial officer, effective November 30, 2026, succeeding interim CFO Claude Russ. Jackson previously served as CFO of AutoZone, Hertz Global Holdings and Nielsen Holdings and currently sits on Eli Lilly’s board. FedEx reported annual revenue of $86 billion. CEO Raj Subramaniam said Jackson’s disciplined financial strategy would support profitable growth.
Citigroup elects James Flanagan as independent director to its board
Citigroup announced that its board elected James (Jim) Flanagan as a new independent director, effective immediately. Flanagan spent nearly 40 years at PricewaterhouseCoopers, including roles as audit partner, practice leader and COO/Vice Chairman from 2014‑2021, overseeing U.S. operations, risk and regulatory matters. He also serves on the boards of Integer Holdings and Cyabra, Inc., where he chairs the Audit Committee.
Bank of America expands board to 14 directors, appoints James Fitterling and William Thomas
On October 21, 2026, Bank of America Corporation announced that its Board of Directors increased its size from 12 to 14 members. The company appointed James Fitterling and William Thomas to the Board, with both individuals beginning their service immediately. This change was disclosed in a Form 8‑K filing with the SEC.
Vertex Pharmaceuticals adds Daniel Brennan to board, expanding it to 11 members
Vertex Pharmaceuticals appointed Daniel Brennan to its board of directors on October 20, 2026, expanding the board to eleven members. Mr. Brennan, EVP and CFO of Boston Scientific, joined the Audit and Finance Committee, received a $400,000 stock unit award vesting in October 2027, and has served on the boards of Waters Corporation since 2022 and Madrigal Pharmaceuticals since 2025, holding an MBA CPA designation.
TJX Companies reports Kenneth Canestrari’s retirement effective April 30, 2027
On October 15, 2026, TJX Companies announced that Kenneth Canestrari will retire on April 30, 2027. His employment agreement was extended to that date, after which he will no longer serve as an executive officer. He will not participate in the Management Incentive Plan, LRPIP for fiscal year 2028 onward, or receive new stock awards, while retaining benefits and remaining subject to confidentiality obligations.
Medtronic appoints Michael Marinaro as President with $1 million salary and $3.25 million long‑term incentives
Medtronic plc appointed Michael Marinaro, EVP and President of Medical Surgical Portfolio, Americas, as President effective Oct. 14, 2026. His base salary was raised to $1,000,000 for fiscal 2027 and he will receive long‑term incentive awards worth $3.25 million, comprising a $1.625 million performance share unit, a $975,000 stock option grant and a $650,000 restricted stock unit, to be granted on Nov. 2, 2026.
Costco approves FY2027 executive bonus plan with up to $1.2 million for CEO
Costco Wholesale Corp disclosed that its Compensation Committee approved fiscal 2027 bonus criteria for executives. Non‑CEO officers are eligible for a base bonus of $400,000, split equally between sales and pre‑tax income targets, with potential payouts up to 120% of each target and up to $80,000 for environmental and social goals. The CEO’s base bonus is $1.2 million, plus up to $200,000 for ESG metrics.
AbbVie expands board to 13 directors, appoints Dr. John M. Carethers as Class II director
AbbVie Inc. announced on October 14, 2026 that it increased its Board of Directors from twelve to thirteen members and appointed Dr. John M. Carethers as a Class II director. Dr. Carethers, Vice Chancellor for Health Sciences at UC San Diego and former Avantor director, will serve on the Public Policy and Sustainability Committee and will receive compensation for independent directors as disclosed in the company’s Form 10‑Q for the quarter ended March 31, 2025.
Halliburton appoints David C. Hernandez to its board of directors
On October 15, 2026, Halliburton announced the appointment of David C. Hernandez as a director, filling a vacancy and keeping the board at 12 members. Hernandez, president and director of Hunt Consolidated, will serve until the 2027 annual meeting and was placed on the Audit Committee and the Health, Safety and Environment Committee. The board determined he is independent under NYSE standards.
Caterpillar appoints Derrick York as group president of Resource Industries after Denise Johnson retirement
On Oct. 15, 2026 Caterpillar Inc. disclosed that Denise Johnson, group president of Resource Industries, will retire effective Feb. 1, 2027 and will serve in an advisory role. Derrick York, president of Solar Turbines and vice president, was appointed group president of Resource Industries effective Nov. 1, 2026. York has led the global industrial gas turbine business since 2023 and has 16 years with Caterpillar.
Merck appoints Paul J. Diaz to Board of Directors effective Nov. 1, 2026
Merck & Co., Inc. announced the election of Paul J. Diaz to its Board of Directors, effective November 1, 2026. The Board also placed Mr. Diaz on the Audit Committee and the Research Committee. He will receive compensation consistent with the company’s non‑employee director compensation practices, and the filing noted he has no related‑party arrangements requiring disclosure.
Charter Communications announces departure of EVP and Chief Commercial Officer Adam Ray
Charter Communications disclosed that Executive Vice President and Chief Commercial Officer Adam Ray will cease his executive duties on October 12, 2026. He will remain a non‑executive advisor through December 31, 2026 and will receive severance and equity treatment as a termination without cause, with unvested RSUs and stock options continuing to vest on the original schedule and vested options exercisable for up to 60 months after the later of his departure or vesting date.
Cigna Group Director Donna F. Zarcone Announces Retirement Effective Dec. 31, 2026
On October 6, 2026, Cigna Group disclosed that board member Donna F. Zarcone will retire from the Board of Directors, with her departure effective December 31, 2026. The filing noted that her retirement is not the result of any disagreement with the Company. The announcement was signed by Executive Vice President and General Counsel Andrea Nelson.
Cisco appoints Girish D. Rishi to Board as independent director
On October 7, 2026 Cisco's Board appointed Girish D. Rishi, CEO of Cognite Holding B.V., as an independent director effective October 9, 2026. He will receive a pro rata portion of the $105,000 annual cash retainer and a fully vested equity award with a grant‑date fair value of a pro rata portion of $270,000. He also entered into the company’s standard indemnity agreement.
General Dynamics appoints Danny Deep as CEO, Phebe Novakovic to become executive chairman
General Dynamics announced that its board elected Danny Deep as chief executive officer effective Jan. 1, 2027, succeeding Phebe Novakovic who will move to the role of executive chairman. Deep, 56, has been president since Dec. 2025 and joined the board on Aug. 5, 2026 after serving in multiple senior positions. The company reported 2025 revenue of $52.6 billion and a workforce of more than 120,000.
Kraft Heinz executive vice president and global general counsel resigns effective Oct. 20, 2026
The Kraft Heinz Company disclosed that Angel S. Willis, Executive Vice President, Global General Counsel and Corporate Affairs Officer, submitted her resignation on October 2, 2026, with her departure effective October 20, 2026. The filing was signed by CFO Andre Maciel on October 6, 2026.
SLB Limited appoints Jing Ulrich to board and Audit and Finance Committees
SLB Limited elected Jing Ulrich to its board and to the Audit and Finance Committees, effective immediately. Ulrich, former Vice Chairman of Investment Banking at JPMorgan Chase (2021‑July 1 2026), also serves on adidas AG’s supervisory board and on boards of Swarovski International Holding and The Wella Company. She holds a BA from Harvard and an MA from Stanford and will sign the indemnity agreement.
IBM elects Frank Baker, Siris Capital co‑founder, to its board of directors
International Business Machines Corp. announced that Frank Baker, 53, was elected to its board of directors effective October 1, 2026. Baker is the co‑founder and Managing Partner of Siris Capital Group, a private‑equity firm that has deployed more than $9 billion of equity capital. The company highlighted his experience in technology investments and leadership roles.
Regeneron filed 8‑K detailing new 2026 performance‑share awards for CEO and CSO
Regeneron Pharmaceuticals disclosed in an 8‑K that its Compensation Committee approved 2026 performance‑share unit (PSU) awards for the chief executive officer and chief scientific officer. The awards provide up to 2,700,000 PSUs for the CEO and 2,900,000 PSUs for the CSO, tied to new product filings, approvals and revenue targets through a performance period from January 1 2026 to December 31 2035.
General Mills names COO Dana McNabb CEO, Jeff Harmening becomes Executive Chair
General Mills announced that its board elected COO Dana McNabb as chief executive officer, effective Jan. 1, 2027, and that Jeff Harmening will serve as executive chair of the board. The filing noted the company delivered $18 billion in fiscal 2026 net sales and has returned over $17 billion to shareholders through dividends and share repurchases in total to date.